Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Aug 15;358(Pt 1):275–280. doi: 10.1042/0264-6021:3580275

In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.

V Rigot 1, E Marbaix 1, P Lemoine 1, P J Courtoy 1, Y Eeckhout 1
PMCID: PMC1222058  PMID: 11485578

Abstract

Most matrix metalloproteinases (MMPs) are secreted as inactive proenzymes. Their expression is well documented in several human tissues, but their activators in vivo are still unknown. To address this question, the activation of progelatinase B (proMMP-9) in the human endometrium was selected as a model system. ProMMP-9 was detected by gelatin zymography in homogenates of fresh endometrial tissue sampled during all phases of the menstrual cycle, whereas its active form was observed only during the late secretory and menstrual phases. Furthermore, proMMP-9 was expressed and activated in endometrial explants sampled outside the perimenstrual phase and cultured in the absence of both progesterone and oestradiol, mimicking the menstrual condition in vivo. Analysis of such tissue cultures by gelatin zymography and Western blotting showed that activation of proMMP-9 depended on a secreted factor and was selectively inhibited by either a synthetic inhibitor of stromelysin 1 (MMP-3) or a monoclonal antibody that specifically blocks MMP-3, thus providing strong evidence for the activation of proMMP-9 in vivo by MMP-3. The activation of proMMP-3 was itself inhibited by a broad-range MMP inhibitor in most cultures, but seemed to involve multiple pathways, implying both serine proteinases and metalloproteinases, which could operate in parallel or sequentially.

Full Text

The Full Text of this article is available as a PDF (165.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkedal-Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., Engler J. A. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4(2):197–250. doi: 10.1177/10454411930040020401. [DOI] [PubMed] [Google Scholar]
  2. Butler T. A., Zhu C., Mueller R. A., Fuller G. C., Lemaire W. J., Woessner J. F., Jr Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol Reprod. 1991 Jun;44(6):1183–1188. doi: 10.1095/biolreprod44.6.1183. [DOI] [PubMed] [Google Scholar]
  3. Cornillie F., Brosens I., Belsey E. M., Marbaix E., Baudhuin P., Courtoy P. J. Lysosomal enzymes in the human endometrium: a biochemical study in untreated and levonorgestrel-treated women. Contraception. 1991 Apr;43(4):387–400. doi: 10.1016/0010-7824(91)90076-r. [DOI] [PubMed] [Google Scholar]
  4. Desrivières S., Lu H., Peyri N., Soria C., Legrand Y., Ménashi S. Activation of the 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol. 1993 Dec;157(3):587–593. doi: 10.1002/jcp.1041570319. [DOI] [PubMed] [Google Scholar]
  5. Devy L., Noël A., Baramova E., Bajou K., Trentesaux C., Jardillier J. C., Foidart J. M., Jeannesson P. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells. Biochem Biophys Res Commun. 1997 Sep 29;238(3):842–846. doi: 10.1006/bbrc.1997.7398. [DOI] [PubMed] [Google Scholar]
  6. Eeckhout Y., Delaissé J. M., Vaes G. Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption. Biochem J. 1986 Nov 1;239(3):793–796. doi: 10.1042/bj2390793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Esser C. K., Bugianesi R. L., Caldwell C. G., Chapman K. T., Durette P. L., Girotra N. N., Kopka I. E., Lanza T. J., Levorse D. A., MacCoss M. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides. J Med Chem. 1997 Mar 14;40(6):1026–1040. doi: 10.1021/jm960465t. [DOI] [PubMed] [Google Scholar]
  8. Fridman R., Toth M., Peña D., Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 1995 Jun 15;55(12):2548–2555. [PubMed] [Google Scholar]
  9. Harris E. D., Jr, Krane S. M. An endopeptidase from rheumatoid synovial tissue culture. Biochim Biophys Acta. 1972 Feb 28;258(2):566–576. doi: 10.1016/0005-2744(72)90249-5. [DOI] [PubMed] [Google Scholar]
  10. Hulboy D. L., Rudolph L. A., Matrisian L. M. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 1997 Jan;3(1):27–45. doi: 10.1093/molehr/3.1.27. [DOI] [PubMed] [Google Scholar]
  11. Jeziorska M., Nagase H., Salamonsen L. A., Woolley D. E. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil. 1996 May;107(1):43–51. doi: 10.1530/jrf.0.1070043. [DOI] [PubMed] [Google Scholar]
  12. Kawahara E., Okada Y., Nakanishi I., Iwata K., Kojima S., Kumagai S., Yamamoto E. The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res. 1993 Apr;84(4):409–418. doi: 10.1111/j.1349-7006.1993.tb00151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kjeldsen L., Johnsen A. H., Sengeløv H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993 May 15;268(14):10425–10432. [PubMed] [Google Scholar]
  14. Lijnen H. R., Silence J., Lemmens G., Frederix L., Collen D. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb Haemost. 1998 Jun;79(6):1171–1176. [PubMed] [Google Scholar]
  15. Lijnen H. R., Silence J., Van Hoef B., Collen D. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice. Blood. 1998 Mar 15;91(6):2045–2053. [PubMed] [Google Scholar]
  16. Makowski G. S., Ramsby M. L. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway. Inflammation. 1998 Jun;22(3):287–305. doi: 10.1023/a:1022300216202. [DOI] [PubMed] [Google Scholar]
  17. Marbaix E., Donnez J., Courtoy P. J., Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11789–11793. doi: 10.1073/pnas.89.24.11789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Marbaix E., Kokorine I., Donnez J., Eeckhout Y., Courtoy P. J. Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation. Hum Reprod. 1996 Oct;11 (Suppl 2):134–143. doi: 10.1093/humrep/11.suppl_2.134. [DOI] [PubMed] [Google Scholar]
  19. Marbaix E., Kokorine I., Henriet P., Donnez J., Courtoy P. J., Eeckhout Y. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J. 1995 Feb 1;305(Pt 3):1027–1030. doi: 10.1042/bj3051027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y., Courtoy P. J. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9120–9125. doi: 10.1073/pnas.93.17.9120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Murphy G., Stanton H., Cowell S., Butler G., Knäuper V., Atkinson S., Gavrilovic J. Mechanisms for pro matrix metalloproteinase activation. APMIS. 1999 Jan;107(1):38–44. doi: 10.1111/j.1699-0463.1999.tb01524.x. [DOI] [PubMed] [Google Scholar]
  22. Nagase H., Enghild J. J., Suzuki K., Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry. 1990 Jun 19;29(24):5783–5789. doi: 10.1021/bi00476a020. [DOI] [PubMed] [Google Scholar]
  23. O'Connell J. P., Willenbrock F., Docherty A. J., Eaton D., Murphy G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem. 1994 May 27;269(21):14967–14973. [PubMed] [Google Scholar]
  24. Obata K., Iwata K., Okada Y., Kohrin Y., Ohuchi E., Yoshida S., Shinmei M., Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta. 1992 Oct 15;211(1-2):59–72. doi: 10.1016/0009-8981(92)90105-y. [DOI] [PubMed] [Google Scholar]
  25. Ogata Y., Enghild J. J., Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem. 1992 Feb 25;267(6):3581–3584. [PubMed] [Google Scholar]
  26. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K., Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992 Oct 25;267(30):21712–21719. [PubMed] [Google Scholar]
  27. Olson M. W., Bernardo M. M., Pietila M., Gervasi D. C., Toth M., Kotra L. P., Massova I., Mobashery S., Fridman R. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J Biol Chem. 2000 Jan 28;275(4):2661–2668. doi: 10.1074/jbc.275.4.2661. [DOI] [PubMed] [Google Scholar]
  28. Ramos-DeSimone N., Hahn-Dantona E., Sipley J., Nagase H., French D. L., Quigley J. P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem. 1999 May 7;274(19):13066–13076. doi: 10.1074/jbc.274.19.13066. [DOI] [PubMed] [Google Scholar]
  29. Rodgers W. H., Matrisian L. M., Giudice L. C., Dsupin B., Cannon P., Svitek C., Gorstein F., Osteen K. G. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest. 1994 Sep;94(3):946–953. doi: 10.1172/JCI117461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Salamonsen L. A., Butt A. R., Hammond F. R., Garcia S., Zhang J. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab. 1997 May;82(5):1409–1415. doi: 10.1210/jcem.82.5.3920. [DOI] [PubMed] [Google Scholar]
  31. Sang Q. X., Birkedal-Hansen H., Van Wart H. E. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta. 1995 Sep 6;1251(2):99–108. doi: 10.1016/0167-4838(95)00086-a. [DOI] [PubMed] [Google Scholar]
  32. Singer C. F., Marbaix E., Lemoine P., Courtoy P. J., Eeckhout Y. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem. 1999 Jan;259(1-2):40–45. doi: 10.1046/j.1432-1327.1999.00001.x. [DOI] [PubMed] [Google Scholar]
  33. Skinner J. L., Riley S. C., Gebbie A. E., Glasier A. F., Critchley H. O. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod. 1999 Mar;14(3):793–799. doi: 10.1093/humrep/14.3.793. [DOI] [PubMed] [Google Scholar]
  34. Zhang J., Fujimoto N., Iwata K., Sakai T., Okada Y., Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta. 1993 Oct 15;219(1-2):1–14. doi: 10.1016/0009-8981(93)90192-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES